<DOC>
	<DOCNO>NCT02248636</DOCNO>
	<brief_summary>This study try determine stop certain medication use treat dementia cause worsen . All participant take pill look identical , may contain active drug inactive pill ( placebo ) . Half group receive treatment taking study -- call `` sham discontinuation '' arm . The half receive reduce dose medication , inactive pill ( placebo ) -- call `` real discontinuation '' arm . Participants able return previous dose medication time study . The percentage people return measure compare . Other medical event factor behavior , think , caregiver distress , measure compare group .</brief_summary>
	<brief_title>Cholinesterase Inhibitor Discontinuation</brief_title>
	<detailed_description>There reliable finding control trial discontinuation cholinesterase inhibitor . It unknown point medication effect , safely discontinue . The investigator identify Veterans take cholinesterase inhibitor ( CI ) ( donepezil galantamine ) least one year . After informed consent , investigator randomize Real Taper ( half-dose CI take 3 week , placebo 3 week ) , Sham Taper ( continue full dose CI take 6 week ) . The pill blind over-encapsulating drug placebo . An intake interview ascertain history measure behavior , cognitive symptom , mood , well caregiver burden . Phone call ass treatment use adverse event week 2 week 4 . An exit interview week 6 measure variable baseline . Participants unblinded point know treatment use . A follow-up call 12 week ascertain ongoing treatment adverse event . At point study , participant caregiver able return pre-study dose medication . The primary outcome percentage participant successfully complete 6-week discontinuation . This compare arm . Other outcomes related medical event ( e.g . hospitalization , fall ) , symptom ( e.g . cognition , behavior ) , caregiver distress measure compare .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Males female age 60 older . Taking stable dose donepezil 10mg great per day , galantamine 8mg great per day , least 2 year . Presence primary caregiver assume responsibility medication compliance , OR residence nursing home Primary care visit within last 12 month . Willing CI medication discontinue . Terminal medical condition life expectancy would less 6 month . Parkinson 's Disease Presence uncontrolled systemic illness would interfere participation study . Unstable medical condition . Receiving service hospice . Current prescription one CI Receiving medication investigational drug study .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Cholinesterase inhibitor</keyword>
	<keyword>Discontinuation</keyword>
</DOC>